Rancho BioSciences (United States)

Institution (Company)

Homepage ROR

Also Known As

Rancho BioSciences (United States)

174

Publications

5.3K

Citations

Authors

Concepts

About

Rancho BioSciences (United States) is a company institution in Rancho Santa Fe, United States known for medicine, systems biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	32	1.8K
2	Engineering	4	16	251
3	Health Sciences	1	2	142
4	Management	1	2	98
5	Natural Sciences	1	3	903

Rancho BioSciences (United States)

174

Publications

5.3K

Citations

Page 1

	Year	Citations
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell, Blood	2018	478
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell, Leukemia	2018	440
The NCATS BioPlanet – An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical Genomics Ruili Huang, Ivan Grishagin, Yuhong Wang, Frontiers in Pharmacology Environmental SignalingIntegrated PlatformMolecular BiologyGene Regulatory NetworkBioinformatics Database	2019	301
Replicable and Coupled Changes in Innate and Adaptive Immune Gene Expression in Two Case-Control Studies of Blood Microarrays in Major Depressive Disorder Gwenaël G. R. Leday, Petra E. Vértes, Sylvia Richardson, Biological Psychiatry	2017	220
Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma Sarah Gooding, Naser Ansari‐Pour, Fadi Towfic, Blood	2020	151
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade Barzin Y. Nabet, Habib Hamidi, Myung Chang Lee, Cancer Cell Cancer ImmunosurveillanceMedicineImmune HeterogeneityImmunologyBronchial Neoplasm	2024	121
PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors Sanju Sinha, Rahulsimham Vegesna, Sumit Mukherjee, Nature Cancer Tumor BiologyTumor HeterogeneityMedicineSingle Cell SequencingCancer Genomics	2024	71
NCATS Inxight Drugs: a comprehensive and curated portal for translational research Vishal B. Siramshetty, Ivan Grishagin, Ðắc-Trung Nguyễn, Nucleic Acids Research DatabasesPharmacotherapyUnited StatesDrug ClassTranslational Pharmacology	2021	49
Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease Mike J. Mason, Carolina Schinke, Christine Eng, Leukemia EngineeringEpigenetic ChangeGeneticsPathologyGene Expression Profiling	2020	49
A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease Sarah G. Aldous, Edward J. Smith, Christian Landles, Brain Genome InstabilityDevelopmental BiologyGenetic DisorderGeneticsHuntingtin Gene	2024	48

Page 1